Sarmad Sadeghi

5PUBLICATIONS
86CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 09, 2026
Integrating NECTIN4 Amplification With Membranous Nectin-4 Expression to Develop a Scoring System for Predicting Enfortumab Vedotin Response in Urothelial Carcinoma.

|Nov 18, 2025
Systemic Therapy for Muscle-Invasive Urothelial Carcinoma of the Bladder (Muscle-Invasive Bladder Cancer): Insights From Real-World Data.

Sarmad Sadeghi, Primo N Lara, Andrea Necchi

|Sep 11, 2025
End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer.

Andrea Necchi, Matthew D Galsky, Nazli Dizman

|Aug 19, 2022
EphrinB2 Inhibition and Pembrolizumab in Metastatic Urothelial Carcinoma.

Sarmad Sadeghi, David Quinn, Tanya Dorff

|Aug 10, 2019
Influence of the facility caseload on the subsequent survival of men with localized prostate cancer undergoing radical prostatectomy.

Afsaneh Barzi, Primo N Lara, Denice Tsao-Wei

Pageof 1

Frequent Collaborators

2 joint publications

Sumanta Pal

2 joint publications

Seth P Lerner

2 joint publications

Primo N Lara

2 joint publications

Andrea Necchi